The report forecasts the global female contraceptive market to grow at a CAGR of 3.48% during the period 2016-2020.
The report has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Female contraceptives such as birth control pills are generally consumed to prevent pregnancy. However, their consumption has increased over time for other purposes other than avoiding pregnancy. In 2013, 1.5 million women globally used oral contraceptive pills for non-contraceptive benefits, like relief from menstrual pain, polycystic ovarian disease, reduction of acne, and regulation of the menstrual cycle.
According to the report, innovation and effectiveness of female contraceptives constitute the key to market growth. Several vendors are entering into strategic alliances and investing in R&D for product innovation and better financial stability, thereby developing the latest products with better efficiency, safety, and protection. These strategic decisions help companies generate revenue and acquire a significant share of the market.
Further, the report states that sexual norms, behaviors, and attitudes are undergoing a transformation globally. There has been an increase in the exploration of sexual fantasies because of increased exposure to the internet, TV shows, and erotic fiction like the Fifty Shades of Grey. The current generation is embracing changes in the perception toward experimentation regarding sex. They are also aware of the importance of protection during sex. IUDs and contraceptive pills help in preventing pregnancy for a longer duration of time if taken in the right way. Despite the economic slowdown, there are new as well as niche players entering the market.
- Merck Millipore
- Teva Pharmaceuticals
Key Topics Covered:
PART 01: Executive summary
PART 02: Scope of the report
PART 03: Market research methodology
PART 04: Introduction
PART 05: Market landscape
PART 06: Geographical segmentation
PART 07: Product segmentation
PART 08: Market drivers
PART 09: Impact of drivers
PART 10: Market challenges
PART 11: Impact of drivers and challenges
PART 12: Market trends
PART 13: Vendor landscape
PART 14: Key vendor analysis
PART 15: Appendix
For more information about this report visit http://www.researchandmarkets.com/research/k5873z/global_female
Research and Markets
Laura Wood, Senior Manager
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/global-female-contraceptive-market---analysis-technologies--forecasts-to-2020---growing-cases-of-sexually-transmitted-diseases-stds---research-and-markets-300359092.html
SOURCE Research and Markets